News
Hosted on MSN2mon
FOLD Q1 Earnings and Sales Miss Estimates, Stock Falls - MSNAmicus Therapeutics FOLD reported first-quarter 2025 adjusted earnings of 3 cents per share, which missed the Zacks Consensus Estimate of 8 cents. The company had reported a loss of 2 cents per ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback